FRC's Tony Perkins Comments on the FDA's Dangerous Approval of Generic Abortion Drug

WASHINGTON, D.C. -- Family Research Council President Tony Perkins released the following statement reacting to the Food and Drug Administration's approval of a generic form of the abortion drug mifepristone hours ahead of the government shutdown:

"Despite the mounting evidence of the dangers of the abortion kill pills, the FDA approved a generic version of mifepristone just hours before the federal government shutdown. Under Biden-era policies, abortionists are operating like Amazon, shipping the life-ending drugs to anyone who clicks send. The Trump administration must change the Biden-era policy that is undermining the pro-life laws that dozens of states have enacted since Dobbs recognized their right to do so. The federal government is undermining states and the intent of the Dobbs decision," Perkins concluded.

Mary Szoch, FRC's Director of Center for Human Dignity, also commented:

"The approval of another generic form of mifepristone should never have been granted. The latest data shows 11 percent of women have a serious complication following the use of this drug, and so a review of the drug is taking place. The FDA's expansion of the availability of mifepristone demonstrates the immediate need for the results of an unbiased, transparent review. As the FDA waits for that review to take place, we call on them to courageously reinstate the original safety measures for mifepristone strengthened with a requirement for an ultrasound. This will at least mitigate the danger to women and the unborn as we wait for this dangerous drug's approval to ideally be revoked."

-30-